Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$4.39B
sum of reported positions
Reported positions
647
Changes vs prior quarter
694
125 new · 133 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 291 measured positions in 8 quarters, the typical new or larger position finished +1.9 pts against the S&P 500 and 56% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.01M | $208M | 4.7% | |
| 1.11M | $127M | 2.9% | |
| 1.02M | $124M | 2.8% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $3.68B | $4.39B |
| Positions | 655 | 647 |
| Biggest line | — | Royal Bank of Canada 5% |
| 1.35M |
| $117M |
| 2.7% |
| 3.62M | $88.7M | 2.0% |
| 1.58M | $85M | 1.9% |
| 461K | $81.3M | 1.9% |
| 1.94M | $76.6M | 1.7% |
| 1.38M | $75M | 1.7% |
| 382K | $59.2M | 1.4% |
| 2.39M | $59.2M | 1.3% |
| 281K | $56.2M | 1.3% |
| 452K | $51.6M | 1.2% |
| 168K | $48.6M | 1.1% |
| 1.3M | $47.9M | 1.1% |
| 1.03M | $47.6M | 1.1% |
| 120K | $43.6M | 1.0% |
| 822K | $43.5M | 1.0% |
| 2.01M | $43.2M | 1.0% |
| 120K | $42.9M | 1.0% |
| 3.25M | $41M | 0.9% |
| 2.55M | $40.5M | 0.9% |
| 1.59M | $39.7M | 0.9% |
| 602K | $39.5M | 0.9% |
| 689K | $39.4M | 0.9% |
Ambarella (AMBA)
107K → 116K shares (+9%)
Central Garden & Pet Co
229K → 256K shares (+12%)
Foster L B (FSTR)
13K → 218K shares (+1618%)
Credo Technology Group Holding (CRDO)
43K → 36K shares (−16%)
Hudbay Minerals (HBM)
590K → 414K shares (−30%)
Financial Institutions (FISI)
233K → 249K shares (+7%)
Alto Ingredients (ALTO)
1M → 1.7M shares (+70%)
Travere Therapeutics (TVTX)
182K → 168K shares (−8%)
Benchmark Electronics, Inc. (BHE)
85K → 96K shares (+14%)
ArcBest Corp. (ARCB)
66K shares
Spectrum Brands Holdings (SPB)
101K → 110K shares (+10%)
Aurinia Pharmaceuticals (AUPH)
210K → 551K shares (+163%)
Mda Space (MDA)
226K shares
Fortuna Mining (FSM)
1.3M → 1.1M shares (−16%)
PBF Energy (PBF)
179K → 203K shares (+14%)
Gentherm Incorporated (THRM)
206K → 270K shares (+31%)
OFG Bancorp (OFG)
188K shares
Applied Materials (AMAT)
15K → 13K shares (−15%)
Pacira BioSciences, Inc. (PCRX)
331K → 363K shares (+10%)
Rbb Bancorp (RBB)
221K → 327K shares (+48%)
Carter Bankshares (CARE)
264K shares
Eli Lilly (LLY)
8,512 → 7,452 shares (−13%)
Tompkins Financial Corporation (TMP)
93K → 94K shares (+1%)
Ibex (IBEX)
264K → 291K shares (+10%)
Tutor Perini Corporation (TPC)
103K → 106K shares (+3%)